Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...

Women have long faced more challenges than men while making their way to the uppermost ranks of prominent companies. And it’s ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.

As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on Friday, Wall Street ...

Major pharmacy chains across the country have been struggling with costs and online competition. CEO Karen Lynch of CVS ...

In a tight, historically expensive presidential election, both candidates are seeking the support of powerful business ...

The proposal would require private health insurance plans to cover daily over-the-counter birth control pills and emergency ...

Karen Lynch frequently spoke of how her mother's death from suicide and her aunt's death from cancer shaped her health care ...

CVS Health (NYSE:CVS) has made a significant leadership change, replacing CEO Karen Lynch with David Joyner as the company ...

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $82.00. The ...